000 01675 a2200469 4500
005 20250517010448.0
264 0 _c20150629
008 201506s 0 0 eng d
022 _a1365-2249
024 7 _a10.1111/cei.12573
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHeikal, N M
245 0 0 _aLaboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
_h[electronic resource]
260 _bClinical and experimental immunology
_cMay 2015
300 _a218-26 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibodies, Anticardiolipin
_xblood
650 0 4 _aAntiphospholipid Syndrome
_xblood
650 0 4 _aBiomarkers
_xblood
650 0 4 _aEnzyme-Linked Immunosorbent Assay
_xmethods
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G
_xblood
650 0 4 _aImmunoglobulin M
_xblood
650 0 4 _aLupus Coagulation Inhibitor
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPhosphatidylserines
_ximmunology
650 0 4 _aProspective Studies
650 0 4 _aProthrombin
_ximmunology
650 0 4 _abeta 2-Glycoprotein I
_ximmunology
700 1 _aJaskowski, T D
700 1 _aMalmberg, E
700 1 _aLakos, G
700 1 _aBranch, D W
700 1 _aTebo, A E
773 0 _tClinical and experimental immunology
_gvol. 180
_gno. 2
_gp. 218-26
856 4 0 _uhttps://doi.org/10.1111/cei.12573
_zAvailable from publisher's website
999 _c24471551
_d24471551